Cortical morphology alterations in non-COVID-19 post-infectious olfactory dysfunction.

Publication date: Dec 23, 2025

Type	Source	Name
disease	MESH	COVID-19
drug	DRUGBANK	Guanosine
pathway	REACTOME	Reproduction
disease	MESH	included
drug	DRUGBANK	Coenzyme M
disease	MESH	viral infections
disease	MESH	parosmia
pathway	KEGG	Viral replication
disease	MESH	upper respiratory tract infection
disease	MESH	atrophy
disease	MESH	cortical thinning
disease	MESH	neuroinflammation
disease	MESH	infection
disease	MESH	inflammation
disease	MESH	anosmia
drug	DRUGBANK	Choline
drug	DRUGBANK	Creatine
drug	DRUGBANK	Water
disease	MESH	parainfluenza
disease	MESH	asymptomatic infection
disease	MESH	Taste Disorder
disease	MESH	head trauma
drug	DRUGBANK	Ethanol
drug	DRUGBANK	Phenylethyl alcohol
drug	DRUGBANK	Flunarizine
disease	MESH	Image
disease	MESH	spm
disease	MESH	PBT
disease	MESH	IBM
disease	MESH	Allergy
drug	DRUGBANK	Vorinostat
disease	MESH	hepatitis
disease	MESH	strain
disease	MESH	edema
disease	MESH	injury
disease	MESH	cognitive impairment
disease	MESH	fatigue
disease	MESH	Dis
disease	MESH	dysgeusia
disease	MESH	Neurologic symptoms
drug	DRUGBANK	Sulpiride
disease	MESH	PVOD
pathway	REACTOME	Apoptosis

(Visited 1 times, 1 visits today)

The Next-Generation Of Scientific Exploration And Research